180 related articles for article (PubMed ID: 12499272)
41. VEGF trap in combination with radiotherapy improves tumor control in u87 glioblastoma.
Wachsberger PR; Burd R; Cardi C; Thakur M; Daskalakis C; Holash J; Yancopoulos GD; Dicker AP
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1526-37. PubMed ID: 17234361
[TBL] [Abstract][Full Text] [Related]
42. Heat shock protein 27-targeted heptapeptide of the PKCΔ catalytic V5 region sensitizes tumors with radio- and chemoresistance.
Lee HJ; Kim EH; Seo WD; Choi TH; Cheon GJ; Lee YJ; Lee YS
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):221-30. PubMed ID: 21300481
[TBL] [Abstract][Full Text] [Related]
43. Topotecan selectively enhances the radioresponse of human small-cell lung carcinoma and glioblastoma multiforme xenografts in nude mice.
Chastagner P; Kozin SV; Taghian A
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):777-82. PubMed ID: 11395247
[TBL] [Abstract][Full Text] [Related]
44. Disrupting the mTOR signaling network as a potential strategy for the enhancement of cancer radiotherapy.
Dumont FJ; Bischoff P
Curr Cancer Drug Targets; 2012 Oct; 12(8):899-924. PubMed ID: 22831276
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of mTOR enhances radiosensitivity of lung cancer cells and protects normal lung cells against radiation.
Zheng H; Wang M; Wu J; Wang ZM; Nan HJ; Sun H
Biochem Cell Biol; 2016 Jun; 94(3):213-20. PubMed ID: 26999331
[TBL] [Abstract][Full Text] [Related]
46. [Cancer stem cells, cornerstone of radioresistance and perspectives for radiosensitization: glioblastoma as an example].
Chargari C; Moncharmont C; Lévy A; Guy JB; Bertrand G; Guilbert M; Rousseau C; Védrine L; Alphonse G; Toillon RA; Rodriguez-Lafrasse C; Deutsch E; Magné N
Bull Cancer; 2012 Dec; 99(12):1153-60. PubMed ID: 23228708
[TBL] [Abstract][Full Text] [Related]
47. Altered cross-linking of HSP27 by zerumbone as a novel strategy for overcoming HSP27-mediated radioresistance.
Choi SH; Lee YJ; Seo WD; Lee HJ; Nam JW; Lee YJ; Kim J; Seo EK; Lee YS
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1196-205. PubMed ID: 21353161
[TBL] [Abstract][Full Text] [Related]
48. Cytotoxic and radiosensitizing effects of FAK targeting in human glioblastoma cells in vitro.
Storch K; Sagerer A; Cordes N
Oncol Rep; 2015 Apr; 33(4):2009-16. PubMed ID: 25625667
[TBL] [Abstract][Full Text] [Related]
49. The role of mTOR inhibition in augmenting radiation induced autophagy.
Jaboin JJ; Shinohara ET; Moretti L; Yang ES; Kaminski JM; Lu B
Technol Cancer Res Treat; 2007 Oct; 6(5):443-7. PubMed ID: 17877432
[TBL] [Abstract][Full Text] [Related]
50. Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination.
Zhang X; Xu R; Zhang C; Xu Y; Han M; Huang B; Chen A; Qiu C; Thorsen F; Prestegarden L; Bjerkvig R; Wang J; Li X
J Exp Clin Cancer Res; 2017 Sep; 36(1):118. PubMed ID: 28870216
[TBL] [Abstract][Full Text] [Related]
51. The effect of the mTOR inhibitor rapamycin on glucoCEST signal in a preclinical model of glioblastoma.
Xu X; Xu J; Knutsson L; Liu J; Liu H; Li Y; Lal B; Laterra J; Artemov D; Liu G; van Zijl PCM; Chan KWY
Magn Reson Med; 2019 Jun; 81(6):3798-3807. PubMed ID: 30793789
[TBL] [Abstract][Full Text] [Related]
52. The nitric oxide donor JS-K sensitizes U87 glioma cells to repetitive irradiation.
Heckler M; Osterberg N; Guenzle J; Thiede-Stan NK; Reichardt W; Weidensteiner C; Saavedra JE; Weyerbrock A
Tumour Biol; 2017 Jun; 39(6):1010428317703922. PubMed ID: 28653883
[TBL] [Abstract][Full Text] [Related]
53. Predictability, efficacy and safety of radiosensitization of glioblastoma-initiating cells by the ATM inhibitor KU-60019.
Vecchio D; Daga A; Carra E; Marubbi D; Baio G; Neumaier CE; Vagge S; Corvò R; Pia Brisigotti M; Louis Ravetti J; Zunino A; Poggi A; Mascelli S; Raso A; Frosina G
Int J Cancer; 2014 Jul; 135(2):479-91. PubMed ID: 24443327
[TBL] [Abstract][Full Text] [Related]
54. Remodeling of the tumor microenvironment by combined treatment with a novel radiosensitizer, {alpha}-sulfoquinovosylmonoacylglycerol ({alpha}-SQMG) and X-irradiation.
Ohta K; Murata H; Mori Y; Ishima M; Sugawara F; Sakaguchi K; Miura M
Anticancer Res; 2010 Nov; 30(11):4397-404. PubMed ID: 21115885
[TBL] [Abstract][Full Text] [Related]
55. Berberine sensitizes human glioma cells, but not normal glial cells, to ionizing radiation in vitro.
Yount G; Qian Y; Moore D; Basila D; West J; Aldape K; Arvold N; Shalev N; Haas-Kogan D
J Exp Ther Oncol; 2004 Jul; 4(2):137-43. PubMed ID: 15500008
[TBL] [Abstract][Full Text] [Related]
56. Ex vivo cultures of glioblastoma in three-dimensional hydrogel maintain the original tumor growth behavior and are suitable for preclinical drug and radiation sensitivity screening.
Jiguet Jiglaire C; Baeza-Kallee N; Denicolaï E; Barets D; Metellus P; Padovani L; Chinot O; Figarella-Branger D; Fernandez C
Exp Cell Res; 2014 Feb; 321(2):99-108. PubMed ID: 24355810
[TBL] [Abstract][Full Text] [Related]
57. A comparison of the effectiveness of NF-167 and metronidazole as hypoxic cell sensitizers of KHT tumor cells in vitro.
Thomson JE; Rauth AM
Radiat Res; 1974 Dec; 60(3):489-500. PubMed ID: 10881726
[No Abstract] [Full Text] [Related]
58. 5-iodo-2-pyrimidinone-2'-deoxyribose-mediated cytotoxicity and radiosensitization in U87 human glioblastoma xenografts.
Kinsella TJ; Kinsella MT; Seo Y; Berk G
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1254-61. PubMed ID: 17967315
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of Radioresponse and Radiosensitizers in Glioblastoma Organotypic Cultures.
Bayin NS; Ma L; Placantonakis DG; Barcellos-Hoff MH
Methods Mol Biol; 2018; 1741():171-182. PubMed ID: 29392699
[TBL] [Abstract][Full Text] [Related]
60. Proton Therapy and Src Family Kinase Inhibitor Combined Treatments on U87 Human Glioblastoma Multiforme Cell Line.
Cammarata FP; Torrisi F; Forte GI; Minafra L; Bravatà V; Pisciotta P; Savoca G; Calvaruso M; Petringa G; Cirrone GAP; Fallacara AL; Maccari L; Botta M; Schenone S; Parenti R; Cuttone G; Russo G
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
